Satyanarayana V - Evaluation <strong>of</strong> the Impact <strong>of</strong> a Therapeutic Management and Effect <strong>of</strong> Pharmacist Intervention on Children with AsthmaTable 5: Intervention study (Study Group) - Knowledge, attitude and practice assessment in study group before and after intervention.(Assessed Based on Correct Answers)Questions (n=50)Before After % P-ValueIntervention Intervention DifferenceNo % No %Can you name the disease you are suffering from? 12 24 26 52 28 0.001**Do you know which part <strong>of</strong> your body is affected? 2 4 6 12 8 0.1321Do you know what are the causative/ worsening 14 28 31 62 34 0.0039**factors <strong>of</strong> asthma are?Do you know what the symptoms <strong>of</strong> asthma are? 18 36 36 72 36 0.000**Do you know how important to avoid allergens? 8 16 17 34 18 0.2124Do you know which dosage form is good for you? 2 4 15 30 26 0.1141Can you list out the drugs are to be avoided in 0 0 6 12 12 0.1321asthma patients?Do you know about that food items to be avoided 16 32 40 80 48 0.0036**in asthma?Do you know how to manage during a severe or 3 6 12 24 18 0.0914acute asthma attack?Do you know the importance <strong>of</strong> taking regular 6 12 39 78 66 0.005*treatment for asthma?Can you identify the drugs you are taking? 0 0 7 14 14 0.0042**Do you know how long the medication for 0 0 20 40 40 0.0214*asthma should be taken?Do you know how to use an inhaler? 6 12 24 48 36 0.1414Do you know about the side effects <strong>of</strong> the 3 6 5 10 4 0.2141drugs you are taking?Are you satisfied with the way <strong>of</strong> your medication controls 22 44 44 88 44 0.1211your symptoms such as cough or shortness breath?Total corrected answers (Mean ± SD) 7.47 ± 4.21 21.87 ± 13.62 28.80 P
Satyanarayana V - Evaluation <strong>of</strong> the Impact <strong>of</strong> a Therapeutic Management and Effect <strong>of</strong> Pharmacist Intervention on Children with AsthmaTable 6: Intervention study (Control Group) - Knowledge, attitude and practice assessment in study group beforeand after intervention. (Assessed Based on Correct Answers)Questions (n=48)Before After % P-ValueIntervention Intervention DifferenceNo % No %Can you name the disease you are suffering from? 13 27.08 14 29.16 2.08 0.083Do you know which part <strong>of</strong> your body is affected? 0 0 2 4.16 4016 0.532Do you know what are the causative/ worsening factors 12 25 16 33.33 8.33 0.083<strong>of</strong> asthma are?Do you know what the symptoms <strong>of</strong> asthma are? 19 39.58 22 45.83 6.25 0.193Do you know how important to avoid allergens? 7 14.58 8 16.66 2.08 0.334Do you know which dosage form is good for you? 3 6.25 3 6.25 0 0.137Can you list out the drugs are to be avoided in asthma 1 2.08 1 2.08 0 0.095patients?Do you know about that food items to be avoided 6 12.5 6 12.5 0 0.168in asthma?Do you know how to manage during a severe or acute 12 25 14 29.16 4.16 0.083asthma attack?Do you know the importance <strong>of</strong> taking regular 6 12.5 8 16.66 4.16 0.334treatment for asthma?Can you identify the drugs you are taking? 2 4.16 3 6.25 2.09 0.074Do you know how long the medication for asthma 1 2.08 3 6.25 4.17 0.702should be taken?Do you know how to use an inhaler? 6 12.5 7 14.58 2.08 0.064Do you know about the side effects <strong>of</strong> the drugs 3 6.25 4 8.33 2.08 0.839you are taking?15. Are you satisfied with the way <strong>of</strong> your medication 22 45.83 23 47.91 2.08 0.132controls your symptoms such as cough or shortness breath?Total corrected answers (Mean ± SD) 7.87 ± 3.906 8.8 ± 5.829 0.948 P>0.001Statistical Methods: Paired ‘ t ’ and paired proportion test. Effect size: (d) Mild Effect (0.45)REFERENCES1. Howard T.D, Meyers D.A, and Bleecker E.R . Mappingsusceptibility genes for allergic disease. Chest 2003; 123(3):S363-68.2. Biserka cical, Eva Verona, et al. An individualized approach inthe education <strong>of</strong> asthmatic children. Acta Clin Crot, 2008;Vol.47(4): 231-38.3. Asher MI, Keil U , Anderson HR, Beasley R, et al. Internationalstudy <strong>of</strong> asthma and allergies in childhood (ISAAC): rationaleand methods. Eur Respir Jour. 1995; 8(3):483-91.4. Masoli Moosapet, Fabian D, Holt S, Beasley R. The globalburden <strong>of</strong> asthma: executive summary <strong>of</strong> the GINADissemination committee report I. Allergy 2004; 59:469-78.5. Marijke M, Tibosch, Christianne Moosapet, Verhoak, et al.Psychological characteristics associated with the onset andcourse <strong>of</strong> asthma in children and adolescents: A systematicreview <strong>of</strong> longitudinal effects. Pt. education and counseling<strong>2011</strong>; 88:11- 19.6. Global initiative for asthma. Global strategy for asthmamanagement and prevention, revised 2006. Available fromhttp:// www.ginasthma.com/GuidelinesResources.asp.7. Stewart AW, et al; ISAAC steering committee. Internationalstudy for asthma and allergy in childhood. The relationship <strong>of</strong>per capita gross national product to the prevalence <strong>of</strong>symptoms <strong>of</strong> asthma and other atopic diseases in children(ISAAC). Int J Epidemiol, 2001; 30(1):173-179.8. Pearce N, et al. Worldwide trends in the prevalence <strong>of</strong> asthmasymptoms: Phase III <strong>of</strong> the international study <strong>of</strong> asthma andallergies in childhood (ISAAC). Thorax 2007; 62: 758-66.9. Mannino DM, Homa DM, et al. Surveillance for asthma – Unitedstates, 1980- 1999, MMWR 2002; 51:1-13.10. American Lung Association. Trends in asthma morbidity andmortality. Available:.11. Hall MJ, Owings MF. 2000 National Hospital Discharge Survey.Advance data from Vital and Health Statistics, No-329.Hyattsville MD, National Center for Health Statistics, 2002.<strong>Indian</strong> <strong>Journal</strong> <strong>of</strong> <strong>Pharmacy</strong> <strong>Practice</strong> Volume 4 Issue 4 <strong>Oct</strong> - <strong>Dec</strong>, <strong>2011</strong> 47